Formal and informal venous thromboembolism risk assessment and impact on prescribing of thromboprophylaxis: a retrospective cohort study

[1]  W. Ageno,et al.  An update on the global use of risk assessment models and thromboprophylaxis in hospitalized patients with medical illnesses from the World Thrombosis Day steering committee: Systematic review and meta‐analysis , 2021, Journal of thrombosis and haemostasis : JTH.

[2]  S. Qu,et al.  A Caprini Risk Score-Based Cost-Effectiveness Analysis of Enoxaparin for the Thromboprophylaxis of Patients After Nonorthopedic Surgery in a Chinese Healthcare Setting , 2019, Clinical Drug Investigation.

[3]  B. Hunt.  Preventing hospital associated venous thromboembolism , 2019, BMJ.

[4]  A. Amin,et al.  Venous Thromboembolism Prophylaxis and Risk in the Inpatient and Outpatient Continuum of Care Among Hospitalized Acutely Ill Patients in the US: A Retrospective Analysis , 2018, Advances in Therapy.

[5]  Joanne M. Stubbs,et al.  Incidence of in‐hospital and post‐discharge diagnosed hospital‐associated venous thromboembolism using linked administrative data , 2018, Internal medicine journal.

[6]  S. Cannegieter,et al.  Relationship between neighborhood socioeconomic status and venous thromboembolism: results from a population‐based study , 2017, Journal of thrombosis and haemostasis : JTH.

[7]  T. Nokes,et al.  Significant reduction in hospital-acquired thrombosis: impact of national risk assessment and real-time feedback , 2017, Open Heart.

[8]  Lubna Gharaibeh,et al.  Evaluation of venous thromboembolism prophylaxis in a major hospital in a developing country , 2017, International Journal of Clinical Pharmacy.

[9]  K. Bailey,et al.  Predictors of venous thromboembolism recurrence, adjusted for treatments and interim exposures: a population-based case-cohort study. , 2015, Thrombosis research.

[10]  A. Cohen,et al.  Impact of Thromboprophylaxis across the US Acute Care Setting , 2015, PloS one.

[11]  N. Freemantle,et al.  Fatal venous thromboembolism associated with hospital admission: a cohort study to assess the impact of a national risk assessment target , 2013, Heart.

[12]  A. Turpie,et al.  Predictive and associative models to identify hospitalized medical patients at risk for VTE. , 2011, Chest.

[13]  Charles E Mahan,et al.  Venous Thromboembolism Prevention: A Systematic Review of Methods to Improve Prophylaxis and Decrease Events in the Hospitalized Patient , 2010, Hospital practice.

[14]  W. Geerts.  Prevention of venous thromboembolism: a key patient safety priority , 2009, Journal of thrombosis and haemostasis : JTH.

[15]  K. Shojania,et al.  How complete is the evidence for thromboembolism prophylaxis in general medicine patients? A meta-analysis of randomized controlled trials. , 2009, Journal of hospital medicine.

[16]  V. Tapson,et al.  Prevention of venous thromboembolism in medical patients and outpatients , 2009, Nature Reviews Cardiology.

[17]  R. Goldberg,et al.  Venous thromboembolism in the outpatient setting. , 2007, Archives of internal medicine.

[18]  M. Cushman.  Epidemiology and risk factors for venous thrombosis. , 2007, Seminars in hematology.

[19]  J. Douketis,et al.  Meta-analysis: Anticoagulant Prophylaxis to Prevent Symptomatic Venous Thromboembolism in Hospitalized Medical Patients , 2007, Annals of Internal Medicine.

[20]  Ajay Kakkar,et al.  Compliance with recommended prophylaxis for venous thromboembolism: improving the use and rate of uptake of clinical practice guidelines , 2004, Journal of thrombosis and haemostasis : JTH.

[21]  L. Melton,et al.  Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. , 2002, Archives of internal medicine.

[22]  M. Samama,et al.  An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. , 2000, Archives of internal medicine.

[23]  H. Büller,et al.  Physiological Changes Due to Age , 1994, Drugs & aging.